EUVIMEDEUVIMED entdecken
Crossref

Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70

Byron Brook iD, Valerie Duval iD, Soumik Barman iD, Lauren Speciner iD, Cali Sweitzer iD, Asad Khanmohammed iD, Manisha Menon, Kimberly Foster iD, Pallab Ghosh, Kimia Abedi iD, Jacob Koster iD, Etsuro Nanishi iD und 5 weitere

Science Translational Medicine · 24.07.2024 · 16 (757)

DOI: 10.1126/scitranslmed.adm8451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 24.07.2024. Verfasst von Byron Brook und 16 weiteren Autor:innen. Beteiligte Einrichtung: Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Interleukin-12, SARS-CoV-2, mRNA Vaccines, RNA, Messenger. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 90 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) vaccines were pivotal in reducing severe acute respiratory syndrome 2 (SARS-CoV-2) infection burden, yet they have not demonstrated robust durability, especially in older adults. Here, we describe a molecular adjuvant comprising a lipid nanoparticle (LNP)–encapsulated mRNA encoding interleukin-12p70 (IL-12p70). The bioactive adjuvant was engineered with a multiorgan protection (MOP) sequence to restrict transcript expression to the intramuscular injection site. Admixing IL-12–MOP (CTX-1796) with the BNT162b2 SARS-CoV-2 vaccine increased spike protein–specific immune responses in mice. Specifically, the benefits of IL-12–MOP adjuvantation included amplified humoral and cellular immunity and increased immune durability for 1 year after vaccination in mice. An additional benefit included the restoration of immunity in aged mice to amounts comparable to those achieved in young adult animals, alongside amplification with a single immunization. Associated enhanced dendritic cell and germinal center responses were observed. Together, these data demonstrate that an LNP-encapsulated IL-12–MOP mRNA-encoded adjuvant can amplify immunogenicity independent of age, demonstrating translational potential to benefit vulnerable populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-12SARS-CoV-2mRNA VaccinesRNA, MessengerAdjuvants, ImmunologicCOVID-19 VaccinesAnimalsMiceNanoparticlesFemaleCOVID-19BNT162 VaccineSpike Glycoprotein, CoronavirusMice, Inbred C57BLAdjuvants, VaccineHumansLipidsDendritic CellsImmunity, CellularImmunity, HumoralLiposomes

Substanzen

Interleukin-12mRNA VaccinesRNA, MessengerAdjuvants, ImmunologicCOVID-19 VaccinesLipid NanoparticlesBNT162 VaccineSpike Glycoprotein, CoronavirusAdjuvants, VaccineLipids

Autor:innen und Institutionen

  • Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.
  • Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
  • Combined Therapeutics Incorporated, Boston, MA 02135, USA.
  • Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

ORCID-Profile: Byron Brook, Valerie Duval, Soumik Barman, Lauren Speciner, Cali Sweitzer, Asad Khanmohammed, Kimberly Foster, Kimia Abedi, Jacob Koster, Etsuro Nanishi, Ofer Levy, Thomas VanCott, David J Dowling

Zitieren

APA

Brook, B., Duval, V., Barman, S., Speciner, L., Sweitzer, C., Khanmohammed, A., Menon, M., Foster, K., Ghosh, P., Abedi, K., Koster, J., Nanishi, E., Baden, L. R., Levy, O., VanCott, T., Micol, R., & Dowling, D. J. (2024). Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70. Science Translational Medicine, 16(757). https://doi.org/10.1126/scitranslmed.adm8451

Vancouver

Brook B, Duval V, Barman S, Speciner L, Sweitzer C, Khanmohammed A, et al. Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70. Science Translational Medicine. 2024;16(757). doi:10.1126/scitranslmed.adm8451

BibTeX
@article{Brook2024,
  author = {Brook, Byron and Duval, Valerie and Barman, Soumik and Speciner, Lauren and Sweitzer, Cali and Khanmohammed, Asad and Menon, Manisha and Foster, Kimberly and Ghosh, Pallab and Abedi, Kimia and Koster, Jacob and Nanishi, Etsuro and Baden, Lindsey R and Levy, Ofer and VanCott, Thomas and Micol, Romain and Dowling, David J},
  title = {Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70},
  journal = {Science Translational Medicine},
  year = {2024},
  volume = {16},
  number = {757},
  doi = {10.1126/scitranslmed.adm8451}
}
Kostenlos starten →